Finally, the HLA-B*5701 variant, which is currently extensively used in clinical practice because of the associated abacavir hypersensitivity [20,21,22], is widely associated with a significant protective effect by inhibiting HIV replication and delaying infection progression [23,24]. The gene discussed is HLA-B; the disease is infection.